|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Securities borrowed | ||||||||||||||||||||
| Due from brokers, dealers and clearing organizations | ||||||||||||||||||||
| Customers | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Financial instruments owned, at fair value | ||||||||||||||||||||
| Other investments, at cost | ||||||||||||||||||||
| Goodwill and intangible assets | ||||||||||||||||||||
| Furniture, equipment, software, and leasehold improvements, net of accumulated depreciation and amortization | ||||||||||||||||||||
| Deferred tax assets, net of valuation allowance | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Securities loaned | ||||||||||||||||||||
| Financial instruments sold, not yet purchased, at fair value | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Due to brokers, dealers and clearing organizations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Preferred Stock, $0.001 par value 100,000,000 authorized, none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value, 300,000,000 shares authorized, 7,088,142 and 6,918,306 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Restricted stock units | ||||||||||||||||||||
| Accumulated other comprehensive income, net of taxes | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
